206 related articles for article (PubMed ID: 168908)
1. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
Jackson DM
Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
[TBL] [Abstract][Full Text] [Related]
2. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
Dolphin AC; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
[TBL] [Abstract][Full Text] [Related]
3. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
Jackson DM
J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
[No Abstract] [Full Text] [Related]
4. Central action of narcotic analgesics. Part III. The role of endogenous noradrenaline in hyperactivity induced by morphine or fentanyl in mice.
Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1978; 30(4):537-47. PubMed ID: 216979
[TBL] [Abstract][Full Text] [Related]
5. The effect of beta-phenylethylamine on temperature in mice and its possible mechanisms of action.
Jackson DM
Arzneimittelforschung; 1975 May; 25(5):776-80. PubMed ID: 1242322
[TBL] [Abstract][Full Text] [Related]
6. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
Dadkar VN; Dahanukar SA; Sheth UK
Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
[No Abstract] [Full Text] [Related]
7. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
[TBL] [Abstract][Full Text] [Related]
8. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
Dourish CT
Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
[TBL] [Abstract][Full Text] [Related]
9. Catecholaminergic control of thyrotropin secretion.
Montoya E; Wilber JF; Lorincz M
J Lab Clin Med; 1979 May; 93(5):887-94. PubMed ID: 219126
[No Abstract] [Full Text] [Related]
10. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
Dunstan R; Jackson DM
Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
[TBL] [Abstract][Full Text] [Related]
11. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
Handley SL; Thomas KV
Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
[TBL] [Abstract][Full Text] [Related]
12. Central action of phenylethylamine in rats.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
[TBL] [Abstract][Full Text] [Related]
13. Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
Vanderwolf CH; Robinson TE; Pappas BA
Brain Res; 1980 Nov; 202(1):65-77. PubMed ID: 6968619
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced dopaminergic supersensitivity.
Moore KE; Thornburg JE
Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
[No Abstract] [Full Text] [Related]
15. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
Bailey RC; Jackson DM
Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
[No Abstract] [Full Text] [Related]
16. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
Dunstan R; Jackson DM
Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
[TBL] [Abstract][Full Text] [Related]
17. Effect of aliphatic monoamines on motor activity of mice: no direct interaction with dopaminergic D2 receptor.
Widy-Tyszkiewicz E; Członkowski A
Pol J Pharmacol Pharm; 1983; 35(6):467-72. PubMed ID: 6234517
[TBL] [Abstract][Full Text] [Related]
18. Alpha-methyldopamine as a dopaminergic agonist.
Duvoisin RC; Marsden CD
Adv Neurol; 1975; 9():243-8. PubMed ID: 1146655
[No Abstract] [Full Text] [Related]
19. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
[TBL] [Abstract][Full Text] [Related]
20. The influence of LSD on locomotor activity in reserpinized mice.
Grabowska M; Antikiewicz L; Michaluk J
Pol J Pharmacol Pharm; 1974; 26(5):499-504. PubMed ID: 4427810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
